Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania

BACKGROUND: Tuberculosis (TB) is the leading cause of death from an infectious disease and the roll-out of rapid molecular diagnostics for rifampin resistance has resulted in a steady rise in the number of patients with multidrug-resistant (MDR)-TB referred for treatment. Pyrazinamide is used in sus...

Descripción completa

Detalles Bibliográficos
Autores principales: Juma, Saumu Pazia, Maro, Athanasia, Pholwat, Suporn, Mpagama, Stellah G., Gratz, Jean, Liyoyo, Alphonse, Houpt, Eric R., Kibiki, Gibson S., Mmbaga, Blandina T., Heysell, Scott K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367741/
https://www.ncbi.nlm.nih.gov/pubmed/30732572
http://dx.doi.org/10.1186/s12879-019-3757-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367741/
https://www.ncbi.nlm.nih.gov/pubmed/30732572
http://dx.doi.org/10.1186/s12879-019-3757-1

Ejemplares similares